TGNT · Totaligent Inc.

Summary

Totaligent, Inc. entered into an Extension Amendment to its Binding Letter of Intent dated February 11, 2026, with Aetherium Medical, extending the target dates for negotiating definitive agreements and closing the proposed acqui-hire transaction from March 5, 2026, to April 10, 2026. This allows additional time for due diligence and negotiations while extending the binding exclusivity period through April 10, 2026.

Key takeaways

• Extension Amendment entered into on March 4, 2026 (Item 1.01) / as of March 20, 2026 (Exhibit 10.1)
• Binding LOI dated February 11, 2026, for acqui-hire of Aetherium Medical's team, business plan, intellectual property, know-how, contacts, and assets for equity
• Target closing date extended from March 5, 2026, to April 10, 2026
• Binding exclusivity period extended through April 10, 2026
• Signed by Edward C. DeFeudis (CEO, Totaligent) and Ivan Klarich (Managing Director, Aetherium Medical)
• Exhibit 10.1: Extension Amendment to Binding Letter of Intent